how long have glp 1 drugs been on the market GLP-1R Agonists for Weight Loss GLP-1 Antagonists Increase Plan Drug

Waist circumference, waist-to-hip ratio, and metabolic health markers can all support a case for treatment even when BMI alone does not quite meet the standard cutoff

GLP-1 therapy should complement, not replace, appropriate orthopedic or rheumatologic treatment for joint conditions

This observation has influenced how researchers design their retatrutide dosing protocols

Explore the episode topics below, tune in and take control of your arthritis

Losing insurance coverage and stopping overnight

Veterans cohort, for instance, sodium-glucose cotransporter 2 (SGLT2) inhibitors were found to be associated with a higher rate of peripheral artery disease-related surgical events than DPP-4 inhibitors (11.2 vs